Evidence for hypernociception induction following histamine H1 receptor activation in rodents

Life Sciences

Volumn 63, Issue 6, 1998, Pages 463-476

  Malmberg Aiello, Petra ^a   Lamberti, Claudia ^a   Ipponi, Alessandra ^a   Bartolini, Alessandro ^a   Schunack, Walter ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

2 (3 trifluoromethylphenyl)histamine; 2 thiazolyethylamine; Antinociception; Histamine H1 receptors; Hypernociception; Pyrilamine

Indexed keywords

2 (2 THIAZOLYL)ETHYLAMINE; 2 (3 TRIFLUOROMETHYLPHENYL)HISTAMINE DIHYDROGENMALEATE; HISTAMINE DERIVATIVE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR AGONIST; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR; MEPYRAMINE MALEATE; MORPHINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG POTENCY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MOUSE; NOCICEPTION; NONHUMAN; PAIN THRESHOLD; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; HISTAMINE; HISTAMINE AGONISTS; HISTAMINE H1 ANTAGONISTS; MALE; MICE; NOCICEPTORS; PAIN MEASUREMENT; PYRILAMINE; RATS; RATS, WISTAR; RECEPTORS, HISTAMINE H1; RECEPTORS, HISTAMINE H2; THIAZOLES;

ANIMALIA; RODENTIA;

EID: 0032479472     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00295-1     Document Type: Article

References (32)

1. 1. C. NETTI, F. GUIDOBONO, V. SIBILIA, I. VILLA, E. CAZZAMALLI and A. PECILE, Agents Actions 23 247-249 (1988).
2. 2. K.R. GOGAS, L.B. HOUGH, N.B. EBERLE, R.A. LYON, S.D. GLICK, S.J. WARD, R.C. YOUNG and M.E. PARSONS, J. Pharmacol. Exp. Ther. 250 476-484 (1989).
3. 3. A.O. OLUYOMI and S.L. HART, Neuropharmacology 30 1021-1027 (1991).
4. 4. P. MALMBERG-AIELLO, C. LAMBERTI, C. GHELARDINI, A. GIOTTI and A. BARTOLINI, Br. J. Pharmacol. 111 1269-1279 (1994).
5. 5. C. LAMBERTI, A. BARTOLINI, C. GHELARDINI and P. MALMBERG-AIELLO, Pharmacol. Biochem. Behav. 53(3) 567-574 (1996).
6. 6. P.B. DEWS and J.D.P. GRAHAM, Br. J. Pharmacol. 1 278-286 (1946).
7. 7. M.M. RUMORE and D.A. SCHLICHTING, Life Sci. 36 403-416 (1985).
8. 8. C.-L.J. SUN, F.W. HUI and J.P. HANIG, Neuropharmacology 24 1-4 (1985).
9. 9. M.M. RUMORE and D.A. SCHLICHTING, Pain 25 7-22 (1986).
10. 10. D. PAROLARO, G. PATRINI, P. MASSI, P. MAINARDI, G. GIAGNONI, M. SALA and E. GORI, J. Pharmacol. Exp. Ther. 249 324-328 (1989).
11. 11. P.C. BRAGA, E. SOLDAVINI, A. PECILE, V. SIBILIA and C. NETTI, Experientia 52 60-65 (1996).
12. 12. S. MEINI, C. GHELARDINI, M. MALCANGIO, C. DEL BUONO, A. BARTOLINI, A. GIOTTI and P. MALMBERG-AIELLO, Pharmacol. Res. Comm. 20, Suppl. II 236 (1988).
13. 13. C. LAMBERTI, A. BARTOLINI, C. GHELARDINI and P. MALMBERG-AIELLO, Pharmacol. Res. 31 Suppl. 258 (1995).
14. 14. J.-C. SCHWARTZ, J.-M. ARRANG, M. GARBARG, H. POLLARD and M. RUAT, Physiol. Rev. 71 1-51 (1991).
15. 15. S.K. BHATTACHARYA and S.S. PARMAR, Res. Comm. Chem. Path. Pharmac. 49 125-136 (1985).
16. 16. V. SIBILIA, C. NETTI, F. GUIDOBONO, A. PECILE and P.C. BRAGA, Agents Actions, Special Conference Issue C350-C353 (1992).
17. 17. C. NETTI, V. SIBILIA, F. GUIDOBONO, P. VILLANI, A. PECILE and P.C. BRAGA, Neuropharmacology 33 205-210 (1994).
18. 18. C.R. GANELLIN, Pharmacology of histamine receptors, C.R. Ganellin and M.E. Parsons (eds.), 10-102, Wright, Bristol (1982).
19. 19. C. LESCHKE, S. ELZ, M. GARBARG and W. SCHUNACK, J. Med. Chem. 38 1287-1294 (1995).
20. 20. P. MALMBERG-AIELLO, A. BARTOLINI, C. GHELARDINI, W. SCHUNACK and C. LAMBERTI, Eur. Histamine Res. Soc., XXV Annual Meeting, Antwerp, Belgium, 22-25 May, Abstr. p. 32 (1996).
21. 21. C. LAMBERTI, A. IPPONI, A. BARTOLINI and P. MALMBERG-AIELLO, Symposium II: New vistas in CNS pharmacology, Innsbruck, Austria, 12-14 Sept. (1997).
22. 22. J.P. O'CALLAGHAN and S.G. HOLTZMAN, J. Pharmacol. Exp. Ther. 197 533-544 (1976).
23. 23. R. KOSTER, M. ANDERSON and E.J. DE BEER, Fed. Proc. 18 412 (1959).
24. 24. G.E. LEIGHTON, R.E. RODRIGUEZ, R.G. HILL and J. HUGHES, Br. J. Pharmacol. 93 553-560 (1988).
25. 25. J.L. VAUGHT, K. PELLEY, L.G. COSTA, P. SETLER and S.J. ENNA, Neuropharmacology 24 211-216 (1985).
26. 26. J.R. BOISSIER and P. SIMON, Arch. Int. Pharmacodyn. 147 372-387 (1964).
27. 27. T.J. HALEY and W.G. McCORMICK, Br. J. Pharmacol. Chemiother. 12 12-15 (1957).
28. 28. F.B. ALTAFFER, F. DE BALBIAN VERSTER, S. HALL, C.J. LONG and P. D'ENCARNACAO, Physiol. Behav. 5 119-121 (1970).
29. 29. S.J. HILL, Pharmacol. Rev. 42 45-83 (1990).
30. 30. L.J. BRISTOW and G.W. BENNETT, Br. J. Pharmacol. 95 1292-1302 (1988).
31. 31. J.M. MONTI, H. JANTOS, C. LESCHKE, S. ELZ and W. SCHUNACK, European Neuropsychopharmacology 4 459-462 (1994).
32. 32. H. YOKOYAMA, K. ONODERA, K. IINUMA and T. WATANABE, Pharmacol. Biochem. Behav. 47 503-507 (1994).